1. Home
  2. EVLV vs NNNN Comparison

EVLV vs NNNN Comparison

Compare EVLV & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$6.52

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$32.92

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
NNNN
Founded
2013
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
EVLV
NNNN
Price
$6.52
$32.92
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$9.13
N/A
AVG Volume (30 Days)
2.4M
37.0K
Earning Date
02-27-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$136,501,000.00
$6,920,153.00
Revenue This Year
$41.16
N/A
Revenue Next Year
$14.71
N/A
P/E Ratio
N/A
$487.83
Revenue Growth
43.16
N/A
52 Week Low
$2.64
$5.18
52 Week High
$8.91
$55.65

Technical Indicators

Market Signals
Indicator
EVLV
NNNN
Relative Strength Index (RSI) 46.08 45.85
Support Level $7.02 $28.61
Resistance Level $7.29 $33.96
Average True Range (ATR) 0.31 4.30
MACD -0.07 -0.80
Stochastic Oscillator 35.89 8.27

Price Performance

Historical Comparison
EVLV
NNNN

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: